News

Army veteran's bone 'paint' for wounded warriors nears FDA testing phase

ORTHOREBIRTH and Theradaptive Enter into License Agreement for THX-14, a Regenerative Treatment Candidate for Trauma

Theradaptive featured in BioCapital among top biotech startups on the rise.

Regenerative Medicine profile in BioBuzz.

Theradaptive Selected as a Finalist at the 2018 First Coast Innovation Challenge in Boston

Theradaptive selected for Phase II funding under the Defense Health Program Small Business Innovation Research Program to develop orthopedic repair implants with biologic delivery capability. 

Theradaptive partners on a $1.47M DoD Contract to develop next-gen 3D printed drug-eluting spinal fusion devices

© 2017-2019 by Theradaptive, Inc.